Ozempic side effects, and the ones that actually make people stop

The common Ozempic side effects are gastrointestinal: nausea, vomiting, diarrhoea and constipation. They cluster in the first weeks and after each dose increase, which is why the drug is titrated slowly rather than started at the dose that does the work. Ozempic also carries a boxed warning for thyroid C-cell tumour risk and should not be combined with another GLP-1. The practical thing nobody tells you: most people who quit do it during titration, and what decides whether that costs them money is the seller's pause and refund terms, not the sticker price.

7 min read · published Aug 27

The short version

  • 1The common side effects are gastrointestinal, and they cluster in the first weeks and after each dose step.
  • 2Ozempic carries a boxed warning for thyroid C-cell tumour risk and must not be combined with another GLP-1.
  • 3Ozempic is approved for type 2 diabetes. Taking it for weight loss is off-label, which is a decision for a prescriber.
  • 4Most people who stop, stop during titration. Check the pause and refund terms before you pay, not after.

Almost everything people mean by "Ozempic side effects" is gastrointestinal, and almost all of it is front-loaded. Nausea, vomiting, diarrhoea and constipation, concentrated in the first weeks and again for a few days after every dose increase. That pattern is the reason the drug is climbed slowly instead of started at the dose that does the work.

Worth knowing

This is general information, not medical advice. Whether this drug suits you, at what dose, and what to do about a side effect are decisions for the clinician who prescribed it. If something frightens you, contact them rather than a website.

What the manufacturer actually lists

Our drug page states the safety profile as Novo Nordisk publishes it, and it is short enough to read in full:1

Ozempic carries a boxed warning for thyroid C-cell tumor risk and should not be combined with other GLP-1 medicines. The most common side effects are gastrointestinal: nausea, vomiting, diarrhoea and constipation.

Two things in there matter more than the nausea, and get less attention.

The boxed warning. A boxed warning is the strongest one the FDA applies. It does not mean the drug is unsafe for you; it means there is a specific risk your prescriber has to weigh against your history. Bring your family history of thyroid cancer to that conversation without being asked.

Do not stack GLP-1s. This is worth saying plainly because the market makes it easy to do by accident. Somebody on Ozempic through insurance who buys compounded semaglutide online to bridge a gap is on two GLP-1s. Somebody switching from semaglutide to tirzepatide without a gap is briefly on two. Tell each prescriber about the other.

Ozempic is a diabetes drug, and that changes this page

Ozempic is approved for type 2 diabetes.2 Wegovy is the same molecule approved for weight management. If you are taking Ozempic to lose weight, you are taking it off-label, which is legal, common, and a decision that belongs to a licensed clinician rather than to a comparison site.

It matters here for one practical reason: the doses differ. Ozempic tops out lower than Wegovy does, and dose is the main driver of how rough the gastrointestinal effects get. Side-effect accounts you read from someone on 2.4 mg of Wegovy are not describing the same exposure as someone on 1 mg of Ozempic.

In plain English

If you are on this drug for weight rather than blood sugar, the Wegovy side-effect picture is the closer match to what you will experience at the top of the ladder. We wrote the Wegovy side-effect picture separately.

A licensed physician pushing back on how these drugs get talked about, in both directions. Included because a side-effects page should not read as a sales pitch. It is commentary, not clinical guidance for you.

Hair loss, muscle loss, and the ones that are not on the label

Three effects get discussed constantly and none of them is a listed adverse reaction: hair shedding, loss of muscle along with fat, and facial volume loss. They have a cause in common, and it is not the drug reaching for your hair or your face. It is losing weight quickly, which does all three and does them after bariatric surgery and crash dieting too.

That is not a reason to dismiss them. It is a reason to aim the question at the right thing, which is the rate of loss and whether you are eating enough while your appetite is suppressed. We wrote out the hair one and the facial one in full.

Why the timing is the whole story

The manufacturer's schedule holds a patient at each strength for several weeks before stepping up. Every step tends to bring a fresh few days of the same symptoms, then a settling.

Read that as a calendar as much as a price list. You are not judging this drug in week two. You are judging it somewhere past the point where the dose stops moving.

The side effect that costs money

Here is the part that belongs on a price tracker rather than a health site.

The most common reason people abandon a GLP-1 is not a dramatic reaction. It is a rough fortnight during titration, at a moment when they have already paid for a plan. What happens next depends entirely on terms they agreed to before they knew any of this: whether the program lets them hold a dose, pause a month, or get anything back.

Those terms vary far more between sellers than the prices do, and almost nobody checks them while comparing. Three questions, all answerable before you pay:

  • Can I stay at this dose? Some programs escalate on a schedule by default. If you want to sit at a strength for an extra month, you need to know that is allowed.
  • Can I pause? A month off is common and reasonable. A plan that cannot be paused turns a bad fortnight into a cancelled subscription.
  • What happens to a prepaid multi-month plan if I stop? The cheapest prices on our board are usually the longest commitments. That is the trade, and it should be a knowing one.

Every membership fee in that ranking is one we verified on the seller's own page, and where a seller has not published one we could check, the row says so instead of assuming there is none. The plan terms are on each seller's page, linked from every row.

What to do about the nausea itself

We will not be telling you. Not out of caution for its own sake: the answer is genuinely specific to you, and the person who prescribed the drug has your history, knows what else you take, and can change the dose. That is the whole answer.

What we will say is that "push through it" is not the only option and is not always the right one, and that a slower climb is a normal, unremarkable thing for a clinician to agree to. On the brand, it also does not cost anything extra, because the manufacturer's self-pay price is flat across the standard dose range.

The honest summary

Expect gastrointestinal symptoms early and after each step up. Take the boxed warning to your prescriber rather than to a search engine. Do not run two GLP-1s at once. And before you pay anyone, find out what happens if the third week is bad, because that is the scenario that actually ends most people's course.

Sources2
  1. Our Ozempic drug page, safety and indication as the manufacturer publishes them read Aug 22
  2. Novo Nordisk, Ozempic indication read Aug 22For adults with type 2 diabetes, along with diet and exercise, to improve blood sugar ... Only Novo Nordisk manufactures FDA-approved semaglutide medicines, like Ozempic.

Common questions

What are the most common Ozempic side effects?

Gastrointestinal ones: nausea, vomiting, diarrhoea and constipation. They are most pronounced in the first weeks and for a few days after each dose increase, which is why the drug is titrated upward slowly rather than started at the target dose.

How long do Ozempic side effects last?

For most people the early symptoms settle as the body adjusts to a given dose, then return briefly at the next step up. Because the manufacturer's schedule holds each strength for several weeks, the pattern typically repeats over the first few months rather than resolving all at once. Persistent or severe symptoms are a reason to contact your prescriber.

Does Ozempic have a boxed warning?

Yes. Ozempic carries a boxed warning for thyroid C-cell tumour risk, and it should not be combined with other GLP-1 medicines. A boxed warning is the strongest warning the FDA applies and is a specific risk for your prescriber to weigh against your history.

Are Ozempic and Wegovy side effects the same?

They are the same molecule, semaglutide, so the type of side effect is the same. The exposure is not: Wegovy is dosed higher for weight management, and dose is the main driver of how pronounced the gastrointestinal effects are. Ozempic is approved for type 2 diabetes; using it for weight loss is off-label.

Can I take Ozempic and compounded semaglutide together?

No. The manufacturer states Ozempic should not be combined with other GLP-1 medicines, and compounded semaglutide is the same molecule. This matters practically because it is easy to do by accident when bridging a gap in supply or switching sellers. Tell each prescriber about the other.

Read next